UNITED THERAPEUTICS Corp (UTHR) stock
UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3025% above fair value
$591.17−2.14 (-0.36%)
Close on Nov 13, 2026Market cap $25.36BP/E 22.3Yield –
United Therapeutics statistics
104 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 24, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 4.04
- 2.22
- P/OCF Ratio
- 17.74
- 12.99
Enterprise valuationIndustry
- EV / Sales
- 7.31
- 2.57
- EV / EBIT
- 17.63
- 19.31
- EV / FCF
- 26.85
- 22.27
Share statisticsIndustry
- Shares Change (YoY)
- -3.68%
- 10.8%
- Shares Change (QoQ)
- -0.69%
- 0.50%
- Float
- 39M
- 49M
- Shares Held by Insiders
- 9.07%
- 11.7%
- Shares Held by Institutions
- 97.4%
- 56.4%
Short sellingIndustry
- Short Interest
- 2M
- –
- Short Interest Change
- -25.2%
- -0.80%
- Short % of Float
- 4.71%
- 9.01%
- Short % of Shares Outstanding
- 4.28%
- 6.30%
- Days to Cover
- 3.45
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $614.23
- –
- 52-Week Low
- $455.63
- –
- 20-Day Moving Average
- $584.02
- –
- 50-Day Moving Average
- $542.60
- –
- 200-Day Moving Average
- $537.46
- –
- Average True Range (14)
- $18.18
- –
- Price Change (1 Week)
- 5.19%
- -1.15%
- Price Change (1 Month)
- 9.17%
- -4.87%
- Price Change (3 Months)
- 16.3%
- -21.0%
- Price Change (6 Months)
- 3.97%
- -20.6%
- Price Change (YTD)
- 21.3%
- -23.6%
- Price Change (1 Year)
- 28.1%
- -22.4%
- Price Change (3 Years)
- 158.9%
- -29.5%
- Price Change (5 Years)
- 190.7%
- -77.9%
- Price Change (10 Years)
- 340.0%
- -65.4%
- Average Volume (10 Days)
- 527,121
- –
- Average Volume (20 Days)
- 527,296
- –
- Average Volume (90 Days)
- 640,660
- –
- Relative Volume
- 0.73
- 0.70
- Relative Strength Index (14)
- 58.0
- 43.4
- Volatility (1 Year)
- 34.9%
- 80.1%
- Beta (5 Years)
- 0.55
- 1.07
MarginsIndustry
- Pretax Margin
- 47.3%
- -11.6%
- EBITDA Margin
- 44.5%
- -27.7%
- FCF Margin
- 27.2%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- 19.1%
- -49.9%
- Return on Assets (ROA)
- 17.1%
- -40.6%
- Return on Invested Capital (ROIC)
- 26.9%
- -32.9%
- Return on Capital Employed (ROCE)
- 20.6%
- -37.9%
Financial positionIndustry
- Current Ratio
- 4.61
- 3.30
- Quick Ratio
- 3.87
- 2.39
- Interest Coverage
- 111.02
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 1.89%
- 6.82%
- Net Income Growth (YoY)
- -3.22%
- -14.4%
- EPS Growth (YoY)
- 0.34%
- -12.3%
- FCF Growth (YoY)
- -22.7%
- 6.85%
- Revenue Growth (3Y CAGR)
- 18.0%
- 2.25%
- Revenue Growth (5Y CAGR)
- 16.5%
- 6.41%
- EPS Growth (3Y CAGR)
- 22.9%
- 1.30%
- EPS Growth (5Y CAGR)
- 19.3%
- 3.78%
EfficiencyIndustry
- Asset Turnover
- 0.44
- 0.40
- Inventory Turnover
- 2.30
- 2.73
- Revenue Per Employee
- $2.28M
- $429.29K
- Profits Per Employee
- $879.14K
- -$689.41K
- Employee Count
- 1,400
- 74
- WACC
- 7.86%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- $1.51B
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $2.07B
- $17.76M
- Net Cash Per Share
- $48.21
- $0.80
- Equity (Book Value)
- $6.28B
- $53.89M
- Book Value Per Share
- $146.32
- $1.50
- Tangible Book Value
- $6.28B
- $27.13M
- Working Capital
- $2.26B
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$562.40M
- -$1.00M
- FCF Per Share
- $20.22
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 4.85%
- -21.8%
- FCF Yield
- 3.42%
- -9.44%
- Buyback Yield
- 7.89%
- -0.76%
- Shareholder Yield
- 7.89%
- 0.00%
Taxes and interestIndustry
- Interest Expense
- $11.90M
- $2.90M
- Income Tax
- $277.00M
- $73.00K
- Effective Tax Rate
- 18.4%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $295.38
- $19.34
- Graham Upside
- -50.0%
- -46.6%
- Altman Z-Score
- 23.40
- 0.23
- Piotroski F-Score
- 8
- 4
- Beneish M-Score
- -2.26
- -2.63
- Lynch Fair Value
- $510.83
- –
- Lynch Upside
- -13.6%
- -28.9%
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | UTHR | S&P 500 | Difference | UTHR per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +8.8% | -3.0% | +11.8 pts | ||
| 3 months | +17.9% | -2.8% | +20.7 pts | ||
| Year to date | +21.3% | +11.5% | +9.8 pts | ||
| 1 year | +27.9% | +13.5% | +14.4 pts | ||
| 3 years | +162.3% | +77.7% | +84.6 pts | +37.9% | +21.1% |
| 5 years | +190.7% | +72.6% | +118.1 pts | +23.8% | +11.5% |
| 10 years | +365.5% | +308.2% | +57.3 pts | +16.6% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
2M UTHR shares were sold short on Oct 30, 2026, down 25.2% from the previous report, or 4.71% of the shares available to trade. At recent volumes it would take 3.5 days to buy them back. Over the last 20 sessions, 55.8% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 1,837,654 | -25.2% | 532,166 | 3.5 |
| Oct 15, 2026 | 2,457,723 | -31.7% | 957,670 | 2.6 |
| Sep 30, 2026 | 3,596,948 | +28.4% | 995,621 | 3.6 |
| Sep 15, 2026 | 2,800,470 | +36.0% | 717,303 | 3.9 |
| Aug 31, 2026 | 2,059,685 | -2.5% | 428,339 | 4.8 |
| Aug 14, 2026 | 2,112,367 | -9.1% | 599,841 | 3.5 |
| Jul 31, 2026 | 2,322,601 | +11.2% | 420,429 | 5.5 |
| Jul 15, 2026 | 2,088,748 | -1.4% | 378,601 | 5.5 |
| Jun 30, 2026 | 2,117,787 | +3.2% | 727,504 | 2.9 |
| Jun 15, 2026 | 2,052,888 | -6.3% | 442,844 | 4.6 |
| May 29, 2026 | 2,191,540 | -4.9% | 484,885 | 4.5 |
| May 15, 2026 | 2,303,877 | -5.9% | 463,580 | 5.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?